Arch Therapeutics, Inc.
from OTCQB Podcast Hosted by OTC Markets Group
Interested in a new biotechnology product that can help improve the speed of wound care, surgical care, and intervention care? Terrence Norchi, President & CEO of Arch Therapeutics, Inc. (OTCQB: ARTH) explains how the company is developing novel approaches as a medical device company to help in patient treatment.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of OTCQB Podcast?
This episode is 7 minutes long.
When was this OTCQB Podcast episode published?
This episode was published on July 19, 2017.
Can I download this OTCQB Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.